Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older
Clinical trial NCT04798027 · TERMINATED
Trial details
- NCT number
- NCT04798027
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-12
- Primary completion
- 2022-06-27
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.